[Therapeutic efficacy and mechanism of action of ginsenoside Rg1 in treating acute hepatic failure in mice]

Zhonghua Gan Zang Bing Za Zhi. 2017 Mar 20;25(3):217-222. doi: 10.3760/cma.j.issn.1007-3418.2017.03.011.
[Article in Chinese]

Abstract

Objective: To examine the regulatory effect of ginsenoside Rg1 (G-Rg1) on endoplasmic reticulum stress and its effect on hepatocellular apoptosis in carbon tetrachloride (CCl(4))-induced acute liver failure (ALF). Methods: Forty healthy, adult male C57/BL mice were randomly divided into normal saline control (NS) group, G-Rg1 blank control (G-Rg1) group, CCl(4) model (CCl(4)) group, and G-Rg1 preventive treatment (CCl(4)+G-Rg1) group, and an ALF mouse model was established by CCl(4) induction. Blood and liver specimens were collected from all mice upon sacrifice at 12 hours post-intraperitoneal injection. Serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST) and total bilirubin (TBil) levels were determined using commercial test kits. The mRNA expression of glucose-regulated protein 78 (GRP78) and C/EBP homologous protein (CHOP) was measured using real-time PCR. The protein expression of GRP78, CHOP, caspase12, and caspase3 were measured by Western blot. Histological changes in the liver were assessed by hematoxylin-eosin staining, and the expression of GRP78 and caspase3 was detected by immunohistochemistry. Hepatocyte apoptosis was determined using terminal transferase dUTP nick end labeling. Quantitative data were analyzed using one-way ANOVA, and subsequent pairwise comparisons were performed using the LSD-t method. Results: Serum ALT, AST, and TBil levels in the CCl(4)+G-Rg1 group were significantly reduced compared with those in the CCl(4) group (ALT: 691.30 ± 108.06 U/L vs 980.66 ± 110.29 U/L, F = 365.07, P < 0.05; AST: 195.40 ± 15.41 U/L vs 319.44 ± 89.32 U/L, F = 115.64, P < 0.05; TBil: 1.09 ± 0.11 mg/dl vs 1.56 ± 0.12 mg/dl, F = 211.29, P < 0.05). The relative mRNA expression of GRP78 and CHOP was significantly lower in the CCl(4) + G-Rg1 group than in the CCl(4) group (P < 0.05). The relative protein expression of caspase3, GRP78, caspase12, and CHOP was significantly reduced to different extents in the CCl(4)+G-Rg1 group compared with those in the CCl4 group (P < 0.05). The CCl(4) + G-Rg1 group showed reduced liver tissue degeneration and necrosis compared with the CCl(4) group. Furthermore, the CCl(4)+G-Rg1 group showed significantly fewer brown granules in the liver than the CCl4 group (P < 0.05), indicating that G-Rg1 preventive treatment reduced CCl(4)-induced hepatocyte apoptosis. Conclusion: G-Rg1 prophylaxis can inhibit inflammation and reduce hepatocyte necrosis and apoptosis during CCl(4)-induced ALF. Its mechanism may involve the suppression of endoplasmic reticulum stress-related signaling molecules to alleviate hepatocyte endoplasmic reticulum stress and apoptosis. The results of this study suggest that G-Rg1 may inhibit liver inflammation and hepatocyte apoptosis through multiple targets to protect liver function.

目的: 在四氯化碳(CCl(4))诱导的急性肝衰竭模型中,人参皂苷Rg1(G-Rg1)对内质网应激的调节作用,以及对肝细胞凋亡的影响。 方法: 将40只健康成年C57/BL雄性小鼠随机分为等渗盐水对照(NS)组,G-Rg1空白对照(G-Rg1)组,CCl(4)模型(CCl(4))组,G-Rg1预防治疗(CCl(4)+G-Rg1)组,并建立CCl(4)小鼠急性肝衰竭模型。建模12 h后,分别采集各组小鼠血清和肝脏组织,用试剂盒法检测血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TBil)水平;定量PCR法检测肝脏葡萄糖调节蛋白78(GRP78)、C/EBP家族同源蛋白(CHOP)的表达量;Western blot检测GRP78、CHOP、半胱氨酸蛋白酶12(caspase12)、caspase3的表达情况;HE染色评价肝脏组织病理学改变;免疫组织化学法分析GRP78、caspase3的表达情况;TUNEL法检测肝脏组织细胞凋亡情况。计量数据进行单因素方差分析,进一步两两比较采用LSD-t法。 结果: NS组、G-Rg1组、CCl(4)组、CCl(4)+G-Rg1组ALT值分别为(50.12±9.25)U/L、(40.48± 6.38)U/L、(980.66±110.29)U/L和(691.30±108.06)U/L,F = 365.07,P < 0.05;AST值分别为(9.69±2.78)U/L、(9.40±3.84)U/L、(319.44±89.32)U/L和(195.40±15.41)U/L,F = 115.64, P < 0.05;TBil值分别为(0.46±0.13)mg/dl(1 mg/dl = 17.1 μmol/L)、(0.48±0.08)mg/dl、(1.56±0.12)mg/dl和(1.09±0.11)mg/dl,F = 211.29, P < 0.05,CCl(4)+G-Rg1组血清ALT、AST、TBil水平低于CCl(4)组,差异均有统计学意义。CCl(4)+G-Rg1组GRP78、CHOP的mRNA相对表达量均较CCl(4)组下降,差异均有统计学意义(F值分别为34.4、44.1,P值均< 0.05)。Western bolt结果显示CCl(4)+G-Rg1组与CCl(4)组相比,caspase3、GRP78、caspase12、CHOP蛋白相对表达量均有不同程度降低,差异有统计学意义(P值均< 0.05)。CCl(4)+G-Rg1组HE染色显示肝脏组织变性坏死较CCl(4)组轻。TUNEL结果显示CCl(4)+G-Rg1组棕色颗粒物质较CCl(4)组明显减少(F = 330.9,P < 0.05),提示G-Rg1预防治疗可以减轻CCl(4)引起的肝细胞凋亡程度。 结论: G-Rg1预防用药可抑制CCl(4)诱导的小鼠急性肝衰竭的炎症反应,同时可减轻肝细胞坏死和凋亡。其作用机制可能通过抑制内质网应激相关信号分子,改善肝细胞内质网应激进而减轻肝细胞凋亡。结合课题组之前的研究结果提示G-Rg1可能通过多个作用靶点抑制肝脏炎症反应和肝细胞凋亡,实现保护肝脏功能作用。.

Keywords: Apoptosis; Endoplasmic reticulum stress; Gensenoside Rg1; Liver failure; Mice.

Publication types

  • English Abstract